Subscribe to RSS Feed
CTI and Independence Blue Cross study in Health Service Research finds fewer emergency room visits for chronically ill patients treated in patient-centered medical homes
Largest study of its kind shows nearly an 8 percent reduction in emergency visits, primarily for those with diabetes, heart disease and high blood pressure
Is Europe putting cancer research at risk?
Lugano, Switzerland, 25 July 2014. The European Society for Medical Oncology (ESMO), the leading pan-European association representing medical oncology...
Tough decision for Roche following mixed Phase II Trial results for Alzheimer’s drug, says GlobalData Analyst
• Roche faces difficult decision over entering Alzheimer’s disease (AD) drug crenezumab for Phase III clinical trials
EAHP: Apps involving medicines should have pharmacist oversight
The European Association of Hospital Pharmacists (EAHP) has responded to a consultation by the European Commission
ESMO 16 World GI Press Release: International phase III trial shows survival benefit of MM-398 added to standard treatment in post-gemcitabine metastatic pancreatic cancer
Barcelona/Lugano -- Adding the novel MM-398 to standard treatment for metastatic pancreatic cancer patients who have already received gemcitabine improves...
Pooled analysis of two Phase III Trials shows Halaven® (Eribulin) improves survival in advanced breast cancer
Significant survival benefit observed in women with HER2 negative breast cancer
Hospital pharmacists express concern to EMA about access to clinical trial information
The European Association of Hospital Pharmacists (EAHP) has written to the Board of the European Medicines Agency (EMA) expressing concern about proposals to...
British Cardiovascular Society response to open letter concerning NICE draft guidance on statins
The British Cardiovascular Society would like to highlight that the letter sent to NICE regarding their draft lipid guidance, by a number of healthcare...
Lenvatinib Phase III results show significant improvement in progression-free survival in people with Radioiodine-Refractory differentiated Thyroid Cancer
Pivotal phase III data for lenvatinib to be presented in a Head and Neck Cancer oral session at American Society of Clinical Oncology congress (ASCO)
ASCO issues new physician & patient resources on managing obesity-related challenges after a cancer diagnosis
New Tools Are Part of ASCO's Efforts to Address Obesity as a Major Factor in the Nation's Cancer Burden
One Week until The European Summit on Hospital Pharmacy
Next week (14-15 May) a unique event will bring together representatives of hospital pharmacy from 34 countries, alongside spokespeople for a broad range of...
19th Congress of the EAHP looks to the future hospital pharmacist in 2020
A major talking point of last week’s Congress of the EAHP in Barcelona was the future roles and competencies for hospital pharmacists in the year 2020 and...
Takeda announce reference price alignment of Protium (pantoprazole)
Takeda Products Ireland Ltd. would like to announce a price reduction on Protium (pantoprazole) 20mg and 40mg (28 tablet packs). From April 1st 2014, the price...
Gut Microbiota for Health World Summit 2014Gut Microbiota for Health World Summit 2014
Digital press folder #GMFH2014 with extra material now available on www.gutmicrobiotaforhealth.com
Reminder: Raynaud's and Scleroderma Awareness week
A quick note to remind you about Raynaud's and Scleroderma Awareness week taking place between the 21st - 26th of April.